000 | 01429 a2200421 4500 | ||
---|---|---|---|
005 | 20250513192621.0 | ||
264 | 0 | _c19991013 | |
008 | 199910s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI7124 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKurahashi, K | |
245 | 0 | 0 |
_aPathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cSep 1999 |
||
300 |
_a743-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-10 _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPneumonia, Bacterial _xcomplications |
650 | 0 | 4 |
_aPseudomonas Infections _xcomplications |
650 | 0 | 4 |
_aPseudomonas aeruginosa _xpathogenicity |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aShock, Septic _xetiology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aKajikawa, O | |
700 | 1 | _aSawa, T | |
700 | 1 | _aOhara, M | |
700 | 1 | _aGropper, M A | |
700 | 1 | _aFrank, D W | |
700 | 1 | _aMartin, T R | |
700 | 1 | _aWiener-Kronish, J P | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 104 _gno. 6 _gp. 743-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI7124 _zAvailable from publisher's website |
999 |
_c10448719 _d10448719 |